TRINITY BIOTECH INVT LTD - NOTE 4.000% 4/0

CUSIP: 89643QAB4

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Debt / NOTE 4.000% 4/0
Market price (% of par)
81.55%
Total 13F principal
$84,894,650
Principal change
-$450,000
Total reported market value
$69,028,979
Number of holders
6
Value change
-$366,743
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 89643QAB4?
CUSIP 89643QAB4 identifies 89643QAB4 - TRINITY BIOTECH INVT LTD - NOTE 4.000% 4/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TRINITY BIOTECH INVT LTD - NOTE 4.000% 4/0 as of Q1 2017

As of 31 Mar 2017, TRINITY BIOTECH INVT LTD - NOTE 4.000% 4/0 was held by 6 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $84,894,650 in principal (par value) of the bond. The largest 6 bondholders included DEERFIELD MANAGEMENT CO, HIGHBRIDGE CAPITAL MANAGEMENT LLC, LINDEN ADVISORS LP, CITADEL ADVISORS LLC, PALISADE CAPITAL MANAGEMENT LLC/NJ, and Wellesley Asset Management. This page lists 6 institutional bondholders reporting positions for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.